HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $55

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $50 to $55.